✦ LIBER ✦

P-366 Phase I study evaluating flavopiridol (HMR1275, FP) in combination with docetaxel (D) in previously treated non-small cell lung cancer (NSCLC) patients (pts.) (HMR1275B/1008)

✍ Scribed by Kasimis, Basil; Rocha-Lima, Caio; Cogswell, Janet; Rodrigues, Leslie; Mahany, J.J.; Gries, Jean-Michel

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of flavopiridol (HMR1275)

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 280 KB

P-211 Phase II study of docetaxel in com

✍ Calero, Miguel Villalona; Kindwall-Keller, Tamila; Soong, Richie; Diasio, Robert 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 372 KB

A phase I–II study of docetaxel (D) and

✍ Quantin, X; Rebattu, P; Pujol, J; Morere, J; Azarian, M.R; Khial, F; Dumortier, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 112 KB

209 Phase I study of docetaxel (D) (Taxo

✍ Manegold, Chr.; Buchholz, E.; Schwalb, M.; Achterrath, W.; Drings, P. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 155 KB

P-48 Phase I study of nedaplatin (N) in

✍ Nogami, Toshiji; Tamra, Kenji; Kurata, Takayasu; Uejima, Hisao; Nakagawa, Kazhik 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 169 KB

O-185 Overcoming hypothesized antagonism

✍ Davies, A.; Lara, P.; Lau, D.; Mack, P.; Gumerlock, P.; Gandara, D. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 322 KB